Doxycycline as STI Prevention

SOURCE www.nbcnews.com
New public-health movement using doxycycline to prevent STIs shows promising results but raises concerns about drug-resistant infections. Studies on doxycycline as pre-exposure prophylaxis (doxyPrEP) for STI prevention are ongoing, with positive outcomes so far.

Key Points

  • Doxycycline used as post-exposure prophylaxis (doxyPEP) and pre-exposure prophylaxis (doxyPrEP)
  • Studies show significant reduction in STI rates with doxycycline use

Pros

  • Promising results in lowering STI rates
  • Potential to offer choice in STI prevention methods

Cons

  • Concerns about contributing to drug-resistant infections